Mirvetuximab Soravtansine in FRa-Positive, Platinum-Resistant Ovarian Cancer
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Details
Original language | English |
---|---|
Pages (from-to) | 2162-2174 |
Journal | New England Journal of Medicine |
Volume | 2023 |
Publication status | Published - 7 Dec 2023 |
Peer-reviewed | Yes |
External IDs
Scopus | 85179025548 |
---|